Literature DB >> 17659761

Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.

Andrea Marzi1, Daniel A Mitchell, Chawaree Chaipan, Tanja Fisch, Robert W Doms, Mary Carrington, Ronald C Desrosiers, Stefan Pöhlmann.   

Abstract

The C-type lectin DC-SIGN binds to oligosaccharides on the human and simian immunodeficiency virus (HIV, SIV) envelope glycoproteins and promotes infection of susceptible cells. Here, we show that DC-SIGN recognizes glycans involved in SIV sensitivity to neutralizing antibodies and that binding to DC-SIGN confers neutralization resistance to an otherwise sensitive SIV variant. Moreover, we provide evidence that mannose-binding lectin (MBL) can interfere with HIV-1 neutralization by the carbohydrate-specific antibody 2G12.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659761     DOI: 10.1016/j.virol.2007.07.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination.

Authors:  Tao Du; Kai Hu; Jun Yang; Jing Jin; Chang Li; Daniel Stieh; George E Griffin; Robin J Shattock; Qinxue Hu
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

2.  Mannose-binding lectin in HIV infection.

Authors:  Sarah Eisen; Agnieszka Dzwonek; Nigel J Klein
Journal:  Future Virol       Date:  2008-05       Impact factor: 1.831

3.  Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.

Authors:  Yvonne Koedel; Kristin Eissmann; Holger Wend; Bernhard Fleckenstein; Heide Reil
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.

Authors:  Dirk Eggink; Mark Melchers; Manfred Wuhrer; Thijs van Montfort; Antu K Dey; Benno A Naaijkens; Kathryn B David; Valentin Le Douce; André M Deelder; Kenneth Kang; William C Olson; Ben Berkhout; Cornelis H Hokke; John P Moore; Rogier W Sanders
Journal:  Virology       Date:  2010-03-21       Impact factor: 3.616

5.  Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimers.

Authors:  Rafael S Depetris; Jean-Philippe Julien; Reza Khayat; Jeong Hyun Lee; Robert Pejchal; Umesh Katpally; Nicolette Cocco; Milind Kachare; Evan Massi; Kathryn B David; Albert Cupo; Andre J Marozsan; William C Olson; Andrew B Ward; Ian A Wilson; Rogier W Sanders; John P Moore
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.

Authors:  Thijs van Montfort; Adri A M Thomas; Georgios Pollakis; William A Paxton
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

7.  Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

Authors:  Mohamed R Hamed; Richard J P Brown; Carsten Zothner; Richard A Urbanowicz; Christopher P Mason; Anders Krarup; C Patrick McClure; William L Irving; Jonathan K Ball; Mark Harris; Timothy P Hickling; Alexander W Tarr
Journal:  J Innate Immun       Date:  2014-05-15       Impact factor: 7.349

Review 8.  Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?

Authors:  Kubra F Naqvi; Janice J Endsley
Journal:  Front Cell Infect Microbiol       Date:  2020-06-03       Impact factor: 5.293

9.  Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.

Authors:  Marie Borggren; Johanna Repits; Carlotta Kuylenstierna; Jasminka Sterjovski; Melissa J Churchill; Damian F J Purcell; Anders Karlsson; Jan Albert; Paul R Gorry; Marianne Jansson
Journal:  Retrovirology       Date:  2008-03-27       Impact factor: 4.602

Review 10.  Human lectins and their roles in viral infections.

Authors:  Christopher P Mason; Alexander W Tarr
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.